FSP Annual Meeting 2021


WELCOME/OVERVIEW


The FSP’s 47th Annual Pathology Conference: Updates and Practical Approaches in Pathology will be held for the first-time ever as a virtual conference on February 12-14, 2021. Going virtual will allow us to educate our members as well as the larger pathology community on the latest scientific developments in pathology, while ensuring our attendees, faculty members, and supporters are staying safe and healthy from the comfort of their homes. The conference will provide pathologists with education surrounding a wide range of topics and the opportunity to learn and adopt new strategies and tools to aid in the diagnosis and analysis of diseases. Specific topics being covered include pearls and pitfalls in gastrointestinal pathology, breast pathology and genitourinary pathology. 

Registration to the Virtual Conference Includes: 

  • Video presentations for all educational sessions
  • PDF presentations for the educational sessions
  • Live question and answer sessions and the ability to chat live with faculty members
  • Virtual Exhibit Hall to network with our industry partners and to schedule 1:1 private Zoom meetings  
  • Virtual Poster Hall with the opportunity to view all scientific posters
  • Industry sponsored sessions and additional downloadable resources from our industry partners
  • Access to the virtual platform for 60-days after the virtual conference for continued learning
  • The ability to earn up to 12 hours of CME credit

Accessing the Virtual Platform 
Attendees will receive an email from our virtual platform on Monday February 8, 2021 with specific instructions on how to log in and access the virtual platform. If you do not receive your email with information to log in by February 10, 2021, please contact us at meetings@flpath.org.

Future Updates
The FSP will be communicating with attendees through email and through social media to provide updates on the virtual conference, so please be sure to check your email regularly and follow us on social media! 


Register: 
Registration for FSP Annual Meeting 2021 is closed.

FACULTY

Faculty: 


David Andrews, MD

Associate Professor, Department of Pathology and Laboratory Medicine

University of Miami Miller School of Medicine

Miami, FL

Topic: COVID-19 Roundtable Discussion on Testing and Treatment with Live Q&A


Henry D. Appelman, MD

M.R. Abell Professor of Surgical Pathology

Department of Pathology and Clinical Laboratories

University of Michigan

Ann Arbor, MI

Topic: GI Pathology


Edi Brogi MD, PhD

Director of Breast Pathology and Attending Pathologist

Memorial Sloan Kettering Cancer Center

Professor of Clinical Pathology and Laboratory Medicine

Weill Cornell Medical College

New York City, NY 10065

Topic: Breast Pathology


Mark Edgar, MD

Senior Associate Consultant 

Mayo Clinic Florida

Jacksonville, FL

Topic: Liposarcoma and its Mimics 


Jonathan Epstein, MD

Professor of Pathology, Urology, Oncology

Johns Hopkins Medicine

Baltimore, MD

Topic: GU Pathology


Richard Gammon, MD

Medical Director 

One Blood

Orlando, FL

Topic: COVID-19 and its Effects on Blood Banking and Transfusion Medicine 


Ronald E. Giffler, MD, JD

Immediate Past President

Florida Medical Association

President and CEO

FirstPath

Fort Lauderdale, FL


Patrick E. Godbey, MD, FCAP

President 

College of American Pathologists

CEO and Laboratory Director

Southeastern Pathology Associates

Laboratory Director

Southeast Georgia Regional Medical Center

Brunswick, GA

Topic: CAP Update: Advancing Pathology Through Advocacy and Laboratory/Member Programs 


Jennifer Hunt, MD, MEd

Chair

Department of Pathology, Immunology, and Laboratory Medicine

University of Florida

Gainesville, FL

Topic: COVID-19 Roundtable Discussion on Testing and Treatment with Live Q&A


Mark Jentoft, MD

Consultant and Assistant Professor

Mayo Clinic Florida

Jacksonville, FL

Topic: Adult Diffuse Gliomas: An Update on Classification


Jason Lewis, MD

Associate Professor of Pathology

Mayo Clinic Florida

Jacksonville, FL

Topic: Practical Guide to Biliary Diseases of the Liver


Elizabeth Anne Montgomery, MD

Professor of Pathology 

University of Miami

Miami, FL

Topic: A Wry View of Gastritis and Gastric Neuroendocrine Tumors 


Aziza Nassar, MD, MPH, MBA

Chair and Professor, Pathology and Laboratory Medicine 

Mayo Clinic and Foundation

Jacksonville, FL

Topic: Mayo Clinic Laboratory (MCL) Outreach 


Michael Patete, MD

President

Florida Medical Association

Venice, Florida

 


Bobbi S. Pritt, MD, MSc, FCAP

Professor of Laboratory Medicine and Pathology

Chair, Division of Clinical Microbiology

Mayo Clinic

Rochester, MN

Topic: COVID-19 Roundtable Discussion on Testing and Treatment with Live Q&A

AGENDA

Friday, February 12, 2021

8:50 am – 9:00 am
Opening Remarks from FSP President Dr. Morton Levitt
Morton Levitt, MD
9:00 am – 9:45 am
Papillary Neoplasms of the Breast
Edi Brogi, MD, PhD
9:45 am – 10:30 am
Lobular Carcinoma in Situ and Related Lesions
Edi Brogi, MD, PhD
10:30 am – 11:15 am
Microscopy Session: Papillary Neoplasms and LCIS: Problematic Cases
Edi Brogi, MD, PhD
11:15 am – 11:45 am
Live Question and Answer Session with Dr. Brogi
Edi Brogi, MD, PhD; Jesse Lee Kresak, MD (Moderator)
11:45 am – 1:00 pm
Virtual Exhibit Hall Hours
12:00 pm - 12:46 pm
Live Poster Presentations
1:00 pm – 2:00 pm
COVID-19 and its Effects on Blood Banking and Transfusion Medicine and LIVE Q and A
Richard Gammon, MD; Stephen Vernon, MD (Moderator)
2:00 pm – 3:00 pm
COVID-19 Roundtable Discussion on Testing and Treatment with Live Q&A
Bobbi S. Pritt, MD, MSc, FCAP; David Andrews, MD; Jennifer Hunt, MD; Carmen Gomez, MD (Moderator)
3:15 pm - 4:00 pm
Sponsored Session (More info here)

Saturday, February 13, 2021

8:00 am- 9:00 am
Sponsored Session (More info here)
8:50 am – 9:00 am
Opening Remarks from FSP President Dr. Morton Levitt
Morton H. Levitt, MD, MHA, FCAP
9:00 am – 9:45 am
Update in Prostate Cancer Grading
Jonathan Epstein, MD
9:45 am – 10:30 am
Mimickers of Prostate Cancer
Jonathan Epstein, MD
10:30 am – 11:15 am
Microscopy Session: Slide Seminar of Interesting GU Lesions
Jonathan Epstein, MD
11:15 am – 11:45 am
Live Question and Answer Session with Dr. Epstein
Jonathan Epstein, MD; Marilyn Bui, MD, PhD (Moderator)
11:45 am – 1:00 pm
Virtual Exhibit Hall Hours
12:00 pm - 12:46 pm
Live Poster Presentations
1:00 pm – 2:30 pm
Mayo Clinic Mini-Symposium with LIVE Chat Q and A
Aziza Nassar, MD, MPH, MBA; Mark Edgar, MD; Mark Jentoft, MD; Jason Lewis, MD
2:30 pm - 3:00 pm
Live Virtual Book Reading: The Healing Art of Pathology: An Update of An Enduring Source of Inspiration
Marilyn Bui, MD, PhD; Ray Paul (Sarcoma Survivor)
3:00 pm – 4:00 pm
Fellowship Fair Networking Event
4:00 pm – 5:00 pm
Pathologists in Training Roundtable Networking Event

Sunday, February 14, 2021

8:30 am - 8:45 am
Mindfulness and Meditation Session
8:50 am – 9:00 am
Opening Remarks from FSP President Dr. Morton Levitt
Morton H. Levitt, MD, MHA, FCAP
9:00 am – 9:45 am
CAP Update: Advancing Pathology Through Advocacy and Laboratory/Member Programs with Live Q&A
Patrick E. Godbey, MD, FCAP; Morton H. Levitt, MD, MHA, FCAP (Moderator)
9:45 am – 10:15 am
Live Platform Presentations
10:15 am – 10:30 am
Florida Medical Association Update
Ronald Giffler, MD; Michael Patete, MD
10:30 am – 11:15 am
Live FSP Business Meeting and Presentation of Awards
For FSP Members Only
11:15 am – 12:30 pm
Virtual Exhibit Hall Hours
11:30 am - 12:15 pm
Sponsored Session (More info here)
12:30 pm – 1:15 pm
Annoying and Frustrating GI Biopsies- Part 1
Henry D. Appelman, MD
1:15 pm – 2:00 pm
Annoying and Frustrating GI Biopsies- Part 2
Henry D. Appelman, MD
2:00 pm – 2:45 pm
Microscopy Session: GI Biopsies That are fun and Hopefully Informative
Henry D. Appelman, MD
2:45 pm – 3:30 pm
A Wry View of Gastritis and Gastric Neuroendocrine Tumors
Elizabeth Anne Montgomery, MD

*Agenda subject to change without notice.

VENUE

Venue: 

 

hide

 

 

Disney’s Yacht & Beach Club

1700 Epcot Resorts Blvd

Orlando, FL 32830

 

Room Rate: $329/night (plus tax)

Reserve your hotel room by clicking here. You can also call the Disney group reservations line at 407-939-4686 and mention the FSP rate to reserve your room. The group rate is available until January 20, 2021. Any reservations made after this date will be subject to availability.

About Disney’s Yacht & Beach Club

Delight in the formal grace of a grand New England-style yacht club at this lakeside hotel. Relax in the inviting elegance of a plush lobby replete with nautical touches, explore the whimsical Stormalong Bay and rent a variety of watercraft from Bayside Marina. Sharing many amenities with its pastel-toned sister, Disney’s Beach Club Resort, Disney’s Yacht Club Resort is walking distance to Epcot and a convenient boat ride to Disney’s Hollywood Studios.


ACCREDITATION INFORMATION

Accreditation: 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Florida Medical Association and the Florida Society of Pathologists. The Florida Medical Association is accredited by the ACCME to provide continuing medical education for physicians.

The Florida Medical Association designates this live activity for a maximum of 12 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CRITERIA FOR SUCCESS
Statements of credit/participation will be awarded based on the participant’s attendance at each session and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claim credit form at www.flpath.org/claimcme.  If you have questions about this CME/CE activity, please contact the FSP at 904-309-6261. Credit must be claimed by Wednesday, February 24, 2021.

ACTIVITY FORMAT
Virtual/Live Meeting

TARGET AUDIENCE
This activity is designed to meet the needs of practicing physicians, pathologists, and other specialists involved with pathology.

STATEMENT OF NEED
The field of pathology is constantly changing, and many of the most important advances in the field. In the setting of new technology, techniques and advancements in the field, practice gaps are inevitable. As such, pathologists require ongoing educational opportunities to stay current in order to maintain and improve their knowledge and competence in the field.

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, all participants should be able to:

  • Recognize various pathologic and clinical features of prostate cancer.
  • Recognize various pathologic and clinical features of genitourinary carcinoma mimickers including glandular and urothelial mimickers of carcinoma of the bladder.
  • Recognize diagnostic features and pitfalls in the evaluation of papillary neoplasms of the breast.
  • Discuss diagnostic features and pitfalls of lobular carcinoma in situ and related lesions.
  • Discuss diagnostic pitfalls in GI pathology and how to best resolve them when encountered.
  • Describe the evidence for use of convalescent plasma therapy for treatment of COVID-19 patients.
  • Recognize the four common liposarcoma subtypes.
  • Recognize various pathologic and clinical features of diffuse gliomas.
  • Discuss how to correctly diagnose biliary diseases of the liver.
  • Discuss how COVID-19 has affected blood banking and clinical pathology.
  • Describe the two key forms of gastritis

COMMERCIAL SUPPORT
At the time of this printing, full commercial support information was not available. All commercial support will be communicated to attendees in advance of the meeting.

PLANNER DISCLOSURES

  • Qihui Jim Zhai, MD- Has nothing to disclose.
  • Stephen Vernon, MD- Has nothing to disclose.
  • Meg Neal, MD- Has nothing to disclose.
  • Carmen Gomez-Fernandez, MD- Has nothing to disclose.
  • Morton Levitt, MD- Has nothing to disclose.
  • Jesse Kresak, MD- Has nothing to disclose.
  • Vatsal Patel, MD- Has nothing to disclose.
  • Philip Robinson, MD- Has nothing to disclose.
  • Marilyn Bui, MD
    • Role: Planner
    • Commercial Interest: NIH/NCI Grant
    • Type of Relationship:
      • Research Support: Cancer Center Support Grant – Scientific Director
      • Consultant: Epizyme, BMS, Helogic, ContextVision
      • Speaker’s Bureau: Physicians Education Resource
      • Other Financial/Material Support: Travel support to speak on behalf of Digital Pathology Association

FACULTY DISCLOSURES

  • Edi Brogi, MD, PhD- Has nothing to disclose.
  • Richard Gammon, MD- Has nothing to disclose.
  • Jonathan Epstein, MD- Has nothing to disclose.
  • Henry D. Appelman, MD- Has nothing to disclose.
  • Aziza Nassar, MD, MPH, MBA- Has nothing to disclose.
  • Mark Edgar, MD- Has nothing to disclose.
  • Mark Jentoft MD- Has nothing to disclose.
  • Jason Lewis, MD- Has nothing to disclose.
  • Elizabeth Anne Montgomery, MD- Has nothing to disclose.
  • Bobbi S. Pritt, MD, MSc, FCAP, DTMH- Has nothing to disclose.
  • Jennifer Hunt, MD, MEd
  • David Andrews, MD

 

DISCLOSURE OF THE FLORIDA MEDICAL ASSOCIATION
It is the policy of the Florida Medical Association (FMA) to ensure independence, objectivity and scientific rigor in all approved CME content. CME faculty must present evidence-based data, clarify off-label product use and disclose all relevant financial relationships to the audience. The ideas and opinions expressed during jointly provided events do not necessarily reflect those of the FMA, and the FMA’s approval of course content for AMA PRA Category 1 Credits™. does not constitute an endorsement of the ideas, positions or statements contained therein.  Every effort has been made to ensure that all information provided by the joint provider is accurate and current. However, FMA does not accept responsibility for errors or omissions and accepts no liability for any resulting loss or damage. Attendees agree to participate in this CME activity with full knowledge and awareness that they waive any claim they may have against the FMA for injury or other damage that may result in any way from their participation in this activity.
 
.
 
 

SPONSORS/EXHIBITORS

Exhibitors: 

Join us for the 47th Annual Pathology Conference taking place virtually for the first-time ever on February 14-16, 2021.  Going virtual will allow us to educate our members on the latest scientific developments in pathology, while ensuring our attendees, faculty members, and supporters are staying safe and healthy from the comfort of their homes. Our virtual conference will provide many additional benefits to our sponsors that a live conference cannot offer, including:

  • Quality leads that are easier to capture in a virtual environment. As a supporter you will receive all contact information of the attendees that visit your company!
  • The opportunity to reach an even larger audience of pathologists, those that would not normally attend the FSP meeting due to travel.  
  • High-visibility options to incorporate your brand in our virtual spaces. Your logo and advertisements can be placed on our virtual platform and link out to your website or company's page in the virtual platform.
  • Extended exposure, as the platform will be open and accessible to attendees for 60 days after the virtual meeting!
  • Reduced out of pocket expenses, as there will be no travel and hotel expenses for your company!
  • Extra visibility on the virtual platform through our gamification and leaderboard challenge where attendees will win prizes for engaging with your company!

We thank you in advance for enabling us, through your support, to deliver our conference virtually so that we may continue to provide invaluable education to our attendees. 

Sponsor Prospectus

Sponsor Registration

SATELLITE EVENTS

hide

SPECIAL EVENTS

hide

VIRTUAL EXHIBIT HALL

 

 

Aiforia equips pathologists and scientists in preclinical, academic, and clinical labs with the most powerful deep learning artificial intelligence and cloud-based technology to increase the speed, accuracy and consistency of analyzing large and complex medical images across a variety of fields from oncology to neuroscience. Aiforia is composed of an ideal mix of scientists experienced in a variety of medical areas from pathology to cancer diagnostics, software developers who collectively hold over 100 years’ experience in artificial intelligence, and a business team with backgrounds in the pharmaceutical and biotechnology industries.

 


 

 

Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of cancer patients. We target the underlying biology of cancer in Immuno-Oncology, Tumor Drivers/Resistance, DNA Damage Response and Antibody Drug Conjugates. Utilizing precision medicine and biomarker-driven indications we look to dramatically improve five-year survival. Our focus on early disease stages and relapsed patients is to 1) identify and treat patients earlier with curative intent; and 2) support relapsed and refractory patients by tackling primary or acquired resistance.

 


 

 

 

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

 


 

 

Caris Life Sciences ® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS).

 


 

 

Castle Biosciences is a skin cancer diagnostics company focused on providing physicians and patients with personalized, clinically actionable genomic information enabling more accurate treatment plan decisions. From its formation in 2008, Castle Biosciences has applied emerging artificial intelligence techniques in molecular diagnostics to improve patient care and outcomes. Our DecisionDx family of molecular diagnostic tests have the ability to meaningfully impact how cancers are diagnosed and managed (https://castletestinfo.com).
DecisionDx®-Melanoma predicts risk of recurrence or metastasis that can inform decisions on the risk of sentinel lymph node positivity and the intensity of follow-up, surveillance imaging, referral and adjuvant therapy for patients with invasive cutaneous melanoma. The test uses tumor biology to provide an individual risk of melanoma recurrence beyond traditional factors such as AJCC staging criteria and sentinel lymph node status and is supported by consistent evidence in over 25 publications including two meta-analyses showing Level 1A evidence classification.
DecisionDx® DiffDx-Melanoma is a new gene expression profile test designed to reduce diagnostic uncertainty by providing a highly accurate and objective evaluation. DiffDx-Melanoma adds diagnostic clarity leading to a more confident diagnosis and a clearer treatment path for patients.
DecisionDx®-SCC predicts metastatic risk for patients with cutaneous squamous cell carcinoma who have one or more risk factors. The test complements factors commonly used for risk assessment in SCC. The incorporation of DecisionDx-SCC results with traditional risk factors provides additional risk prediction to better inform choices about treatment and follow-up care.
DecisionDx-UM predicts risk of metastasis for patients with uveal melanoma, a rare eye cancer. The test is standard of care in a majority of ocular oncology practices.
Castle Biosciences has active research and development programs for tests in other dermatologic diseases with high clinical need. The company is based in Friendswood, Texas with laboratory operations in Phoenix, Arizona (www.CastleBiosciences.com).

 


 

 

As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.

 


 

 

 

Change Healthcare partners with providers, payers, and consumers to reduce costs, create efficiencies, and effectively manage complex workflows. Together we are accelerating the journey toward improved lives and healthier communities. We also help pathology practices and labs increase cash flow, patient revenue, and coding and compliance with our billing, collection, and revenue cycle management services.

 


 

 

 

Cleveland Clinic Laboratories is dedicated to providing high-quality, clinically impactful pathology and laboratory diagnostic services combined with readily available consultation from experienced pathologists and laboratory scientists. Our laboratories offer excellence in coagulation, flow cytometry, hematopathology, molecular testing and cytogenomics, and microbiology as well as subspecialty services in anatomic pathology. This approach ensures that every specimen submitted will be evaluated by a pathologist with a high level of diagnostic expertise in that specific field of pathology.

 


 

 

 

CSI Laboratories is a leading cancer testing and diagnostics laboratory trusted by pathologists, oncologists, and community hospitals throughout the U.S. For more than 22 years, we've been at the forefront of advanced testing methods, using a collaborative approach to manage testing with speed, precision and care, and delivering testing that is medically necessary and clinicaly significant. CSI provides a full complement of cancer testing, including Flow, Cytogenics, FISH, IHC, and Molecular services. Our national cancer testing laboaratory has one mission: Keeping our clients and their patients at the forefront of everything we do.

 


 

 

 

 

ELITechGroup has been in operation for over 50 years and distributes to over 100 countries. Proud to be the World Leader in Aerospray staining technology and Cytocentrifugation, offering the world's most reliable solutions in performance and reliability. ELITechGroup is confident that this automated technology will elevate the performance of any laboratory and facilitate superior results.

 


 

 

 

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.

 


 

 

Interpace Diagnostics is a leading provider of molecular testing for thyroid and pancreatic cancer.  The Company offers ThyGeNEXT® and ThyraMIR®, a unique approach that combines a mutation panel with a microRNA classifier for Thyroid cancer.  These tests, utilizing the Markers That Matter™, have been fully validated with a demonstrated NPV of 97% and PPV of 75%. Also available are PancraGEN® and PanDNA®, which help in stratifying cancer risk of pancreatic cysts or biliary strictures. By integrating a proprietary combination of tumor suppressor genes and loss of heterozygosity with imaging, chemistries, and other first line testing, a risk classification is determined to help inform the best course of action, from surgery to active surveillance. 

 


 

 

MagMutual is a provider of Medical Malpractice insurance and practice solutions, including patient safety services to over 25,000 physicians and hospitals.

 


 

 

MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians.

 


 

 

Michigan Medicine Laboratories (MLabs) is driving tomorrow’s health care solutions with cutting edge personalized laboratory diagnostics. With 35+ years of reference laboratory experience, our promise and commitment is to deliver the highest quality laboratory results to meet the needs of today’s patient in a cost effective and personalized manner.
 
 

 

 

 

NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore.

 


 

 

 

PIMS Inc. was incorporated in 1998 and has evolved into a full-service Medical Billing and Practice Management Services company. PIMS provides comprehensive billing and consulting services for providers of all sizes. In addition, PIMS offers an innovative and robust laboratory information system designed specifically for the anatomic pathology practice in mind.

 


 

 

 

Roche Diagnostics is one of the world’s leaders in medical diagnostic instrument and reagent systems providing leading-edge automation for use in the diagnosis of cancer and infectious disease.

 


 

 

 

We are building awareness around Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), an aggressive and deadly blood cancer that often presents with skin lesions.  Historically, the average time to diagnosis is 6 months, and following diagnosis the median overall survival is approximately 8 to 14 months.  An early and accurate diagnosis is critical in improving patient outcomes, which is why it is important to include CD123, CD4, and CD56 in your hematologic diagnostic panel.  THINK CD123456! 

 


 

 

 

Vachette is a pathology laboratory consulting firm. We specialize in revenue cycle auditing, reworking revenue cycle processes, and negotiating managed care contracts. Our three-tiered process of revenue strategy, revenue management, and revenue insurance helps our clients find millions of dollars in lost revenue each year. Imagine having a professional team assess your revenue cycle process. How would your billing team perform? We audit over $1 billion in medical billings annually. Isn't it time to see how you score?

 

hide

hide

FSP Welcomes Submissions for Virtual Poster Hall and Poster Competition


Introduction

The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for inclusion in the Virtual Poster Hall during the FSP’s Annual Pathology Conference taking place virtually on February 12-14, 2021. The purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists. All pathologists are invited to submit case-based posters or research-based posters for inclusion in the Virtual Poster Hall. Residents and fellows are eligible to compete in the FSP Poster Competition.

Poster Submission Deadline

January 8, 2021
5:00 pm EST

Poster Competition

Eligibility
Residents and fellows who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology in the state of Florida are invited to submit and are eligible to participate in the FSP Poster Competition.

Poster Competition Presentation Process and Awards
Posters will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the live poster sessions during the virtual conference. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150.

To be considered for the Poster Competition and awards, you must:

  1. Be a resident or fellow in the state of Florida
  2. Submit your poster by the submission deadline.
  3. Be available to present your poster live on either Friday, February 12 or Saturday, February 13

Winners of the Poster Competition will be announced, and prizes will be awarded during the FSP Business Meeting on Sunday, February 14, 2021.

Poster Submission Instructions

Please read through the submission instructions below before preparing your poster:

  1. Submit your poster on this website through the online submission portal below
  2. Register for the Conference and pay the meeting registration fee (if applicable).

General Information and Policies:

  • Lead authors on all submissions are required to register for the conference and pay the applicable registration fee.
  • Residents and fellows participating in the Poster Competition are required to present their poster duriing the live poster sessions for judging in the Competition.
  • Up to four posters may be submitted.
  • It is the responsibility of the submitter to ensure that his/her poster is submitted correctly.
  • Full disclosure of all authors must be provided by the time of submission. Any failure to fully comply with this requirement may result in the poster being withdrawn.
  • If judges deem that a poster must be edited or updated to be eligible for presentation, lead authors will be contacted by email.

Content Guidelines

Poster entries can only be accepted electronically and must adhere to the following guidelines:

  • Posters must have one central theme, include essential data and test, and be visually appealing.
  • Posters must be proofread carefully to avoid errors before submission.
  • Posters must contain generic drug names only.
  • Posters must be submitted in clear English with accurate grammar and spelling of quality suitable for publication.
  • Lead and secondary authors must disclose all financial relationships.
  • Any funding support for the research must be disclosed.
  • Encore research is not eligible for submission.
  • A maximum of 4 references are allowed.

Checklist

You will be asked for the following:

  • Short poster title (40-character title for use on onsite signage)
  • Author name(s)
  • Financial disclosures
  • Disclosure of funding support
  • Topic

The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the poster is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at poster@flpath.org or call Erin Corrales at 904-309-6204.

Poster Topics

The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their poster. Topics are:

  • Blood Banking/Transfusion Medicine
  • Chemical Pathology
  • Clinical Informatics
  • Cytopathology
  • Dermatopathology
  • Forensic Pathology
  • Hematopathology
  • Medical Microbiology
  • Molecular Genetic Pathology
  • Neuropathology
  • Pediatric Pathology
  • Selective Pathology
  • Case Study
  • Other

Poster Templates

Please note, you will be required to use the pre-approved poster template for your poster submission. To download the templates click on the links below:

Resident/Fellow Platform Presentations

Residents and fellows are invited to submit their poster to be considered for an oral podium presentation during a designated session on the conference agenda. If you wish to be considered for an oral podium presentation, you can indicate this on the conference registration form. If selected for an oral podium presentation, you must commit to presenting at the conference and will be contacted by the FSP with further details on the virtual presentation format. Please note this is a separate event from the Poster Competition and residents and fellows will still be required to present their poster as part of this competition to be eligible for the Poster Competition awards. 

Disclaimer

The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at poster@flpath.org or call 904-309-6204.

 

SUBMIT YOUR POSTER NOW

 

NETWORKING EVENTS


The FSP is excited to be able to offer the following valuable networking and career-building opportunity to our pathologists in training attendees.

 

Fellowship Fair

The FSP will host a virtual fellowship fair for residents to meet virtually with the coveted fellowship programs in Florida. This is a unique opportunity for our resident attendees to learn about the pathology fellowship programs available in our wonderful state, to gain advice on the application and interview process and to connect one-on-one with program representatives.

Each fellowship program will have a resource page on the FSP virtual platform containing presentations, videos, and resources available for residents to view on-demand at any time during the virtual conference. Attendees will be able to meet with the program representatives through Zoom meetings to connect and ask questions. The FSP virtual platform will be open on the first day of the FSP meeting on February 12 and will continue to be available to all attendees for 60 days after the meeting allowing attendees the opportunity to continue to view the resources available from the fellowship programs.

This event is open to medical students, residents and fellows attending the FSP virtual conference and is complimentary.

 

Pathologists in Training Roundtable

The FSP will host a virtual roundtable event for pathologists in training covering issues of major significance to residents transitioning from residency to fellowship to practice. During the roundtable event, attendees will participate in intimate and interactive Zoom meetings with roundtable leaders who will cover a different topic of interest. Roundtable leaders will rotate to each group of attendees to share their insight and wisdom.  Our Roundtable leaders will consist of FSP board members and prominent pathology thought leaders representing the various fields of pathology practice and specialties including clinical, laboratory, hospital based and academic.

Roundtable Topics:

  1. Jobs in Florida
  2. How to Choose Fellowship
  3. Virtual Board Format and Virtual Inteview Format for Fellowships

This event is open to medical students, residents and fellows attending the FSP meeting and is complimentary.